Pharmaceutical antitrust: an analysis of US and EU law
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
New York, NY
Institute of Competition Law
2023
|
| Schriftenreihe: | Concurrences
|
| Beschreibung: | XX, 412 Seiten |
| ISBN: | 9781954750104 1954750102 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV049455831 | ||
| 003 | DE-604 | ||
| 005 | 20240122 | ||
| 007 | t | ||
| 008 | 231206s2023 |||| 00||| eng d | ||
| 020 | |a 9781954750104 |9 978-1-954750-10-4 | ||
| 020 | |a 1954750102 |9 1-954750-10-2 | ||
| 035 | |a (OCoLC)1443592965 | ||
| 035 | |a (DE-599)BVBBV049455831 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-M382 |a DE-19 | ||
| 245 | 1 | 0 | |a Pharmaceutical antitrust |b an analysis of US and EU law |c Editors: Mélanie Thill-Tayara ; George G. Gordon |
| 264 | 1 | |a New York, NY |b Institute of Competition Law |c 2023 | |
| 300 | |a XX, 412 Seiten | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Concurrences | |
| 700 | 1 | |a Thill-Tayara, Mélanie |0 (DE-588)1316835332 |4 edt | |
| 700 | 1 | |a Gordon, George G. |0 (DE-588)131683557X |4 edt | |
Datensatz im Suchindex
| _version_ | 1805083793614176256 |
|---|---|
| adam_text | |
| adam_txt | |
| any_adam_object | |
| any_adam_object_boolean | |
| author2 | Thill-Tayara, Mélanie Gordon, George G. |
| author2_role | edt edt |
| author2_variant | m t t mtt g g g gg ggg |
| author_GND | (DE-588)1316835332 (DE-588)131683557X |
| author_facet | Thill-Tayara, Mélanie Gordon, George G. |
| building | Verbundindex |
| bvnumber | BV049455831 |
| ctrlnum | (OCoLC)1443592965 (DE-599)BVBBV049455831 |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>00000nam a2200000 c 4500</leader><controlfield tag="001">BV049455831</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20240122</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">231206s2023 |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781954750104</subfield><subfield code="9">978-1-954750-10-4</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1954750102</subfield><subfield code="9">1-954750-10-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1443592965</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV049455831</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-M382</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmaceutical antitrust</subfield><subfield code="b">an analysis of US and EU law</subfield><subfield code="c">Editors: Mélanie Thill-Tayara ; George G. Gordon</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">New York, NY</subfield><subfield code="b">Institute of Competition Law</subfield><subfield code="c">2023</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XX, 412 Seiten</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Concurrences</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Thill-Tayara, Mélanie</subfield><subfield code="0">(DE-588)1316835332</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gordon, George G.</subfield><subfield code="0">(DE-588)131683557X</subfield><subfield code="4">edt</subfield></datafield></record></collection> |
| id | DE-604.BV049455831 |
| illustrated | Not Illustrated |
| index_date | 2024-07-03T23:13:52Z |
| indexdate | 2024-07-20T07:54:12Z |
| institution | BVB |
| isbn | 9781954750104 1954750102 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-034801637 |
| oclc_num | 1443592965 |
| open_access_boolean | |
| owner | DE-M382 DE-19 DE-BY-UBM |
| owner_facet | DE-M382 DE-19 DE-BY-UBM |
| physical | XX, 412 Seiten |
| publishDate | 2023 |
| publishDateSearch | 2023 |
| publishDateSort | 2023 |
| publisher | Institute of Competition Law |
| record_format | marc |
| series2 | Concurrences |
| spelling | Pharmaceutical antitrust an analysis of US and EU law Editors: Mélanie Thill-Tayara ; George G. Gordon New York, NY Institute of Competition Law 2023 XX, 412 Seiten txt rdacontent n rdamedia nc rdacarrier Concurrences Thill-Tayara, Mélanie (DE-588)1316835332 edt Gordon, George G. (DE-588)131683557X edt |
| spellingShingle | Pharmaceutical antitrust an analysis of US and EU law |
| title | Pharmaceutical antitrust an analysis of US and EU law |
| title_auth | Pharmaceutical antitrust an analysis of US and EU law |
| title_exact_search | Pharmaceutical antitrust an analysis of US and EU law |
| title_exact_search_txtP | Pharmaceutical antitrust an analysis of US and EU law |
| title_full | Pharmaceutical antitrust an analysis of US and EU law Editors: Mélanie Thill-Tayara ; George G. Gordon |
| title_fullStr | Pharmaceutical antitrust an analysis of US and EU law Editors: Mélanie Thill-Tayara ; George G. Gordon |
| title_full_unstemmed | Pharmaceutical antitrust an analysis of US and EU law Editors: Mélanie Thill-Tayara ; George G. Gordon |
| title_short | Pharmaceutical antitrust |
| title_sort | pharmaceutical antitrust an analysis of us and eu law |
| title_sub | an analysis of US and EU law |
| work_keys_str_mv | AT thilltayaramelanie pharmaceuticalantitrustananalysisofusandeulaw AT gordongeorgeg pharmaceuticalantitrustananalysisofusandeulaw |